• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines N-benzylpiperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Benzylpiperidines N-benzylpiperidines

Professional Introduction to 1-Benzylpiperidin-3-one hydrochloride (CAS No. 50606-58-1)

1-Benzylpiperidin-3-one hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 50606-58-1, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This compound belongs to the piperidine class, a heterocyclic organic compound featuring a six-membered ring containing one nitrogen atom. The presence of a benzyl group at the 1-position and a ketone functionality at the 3-position, along with its hydrochloride salt form, imparts unique chemical and pharmacological properties that make it a subject of considerable interest in drug discovery and development.

The structural framework of 1-Benzylpiperidin-3-one hydrochloride contributes to its potential biological activity. Piperidine derivatives are well-documented for their role in various pharmacological applications, including CNS-targeting agents, antiviral drugs, and kinase inhibitors. The benzyl substituent enhances lipophilicity, which can influence membrane permeability and binding affinity to biological targets. The ketone group at the 3-position provides a site for further functionalization, enabling the synthesis of more complex derivatives with tailored properties.

In recent years, there has been growing attention on piperidine-based scaffolds due to their versatility in modulating biological pathways. Specifically, 1-Benzylpiperidin-3-one hydrochloride has been explored in the context of developing novel therapeutic agents. Its molecular structure suggests potential interactions with enzymes and receptors involved in neurological disorders, such as Alzheimer's disease and Parkinson's disease. The compound's ability to cross the blood-brain barrier makes it an attractive candidate for central nervous system (CNS) drug development.

Recent studies have highlighted the importance of optimizing piperidine derivatives for improved pharmacokinetic profiles. Modifications to the benzyl and ketone functionalities can significantly alter the compound's solubility, stability, and metabolic clearance. For instance, derivatization of the ketone group into an amide or ester can enhance bioavailability while reducing toxicity. Such structural modifications are critical in advancing lead compounds toward clinical candidates.

The hydrochloride salt form of 1-Benzylpiperidin-3-one hydrochloride enhances its solubility in aqueous solutions, making it more suitable for formulation into pharmaceutical products. This property is particularly important for oral and parenteral administration, where drug solubility directly impacts absorption rates and therapeutic efficacy. The salt form also improves crystallinity, which is beneficial for controlled-release formulations and long-term stability.

Advances in computational chemistry have enabled more efficient screening of piperidine derivatives like 1-Benzylpiperidin-3-one hydrochloride for biological activity. Molecular docking studies and virtual screening have identified potential binding interactions with target proteins, providing insights into their mechanism of action. These computational approaches complement traditional high-throughput screening (HTS) methods, expediting the discovery process.

In clinical research, 1-Benzylpiperidin-3-one hydrochloride has been investigated as a precursor or intermediate in synthesizing more complex molecules with therapeutic potential. Its role in multi-step synthetic pathways underscores its importance as a building block in medicinal chemistry. Researchers have leveraged its structural features to develop novel compounds targeting various diseases, including cancer and infectious disorders.

The synthesis of 1-Benzylpiperidin-3-one hydrochloride involves well-established organic reactions, including Grignard reactions or nucleophilic additions to carbonyl groups. Recent innovations in synthetic methodologies have improved yield and purity, making large-scale production more feasible. These advancements are crucial for bridging the gap between laboratory research and industrial manufacturing.

Evaluation of 1-Benzylpiperidin-3-one hydrochloride in preclinical models has provided valuable data on its pharmacological effects. Studies have examined its interactions with enzymes such as cytochrome P450 (CYP) isoforms, which are critical for drug metabolism. Understanding these interactions helps predict potential drug-drug interactions and optimize dosing regimens.

The future prospects of 1-Benzylpiperidin-3-one hydrochloride lie in its application across multiple therapeutic areas. Ongoing research aims to expand its utility by exploring new synthetic routes and functionalizing its core structure further. Collaborative efforts between academia and industry are essential to translate these findings into tangible therapeutic benefits for patients worldwide.

In summary,1-Benzylpiperidin-3-one hydrochloride (CAS No. 50606-58-1) represents a promising compound with diverse applications in pharmaceutical research. Its unique structural features make it a valuable tool for developing novel drugs targeting neurological and other diseases. Continued investigation into its properties and potential will undoubtedly contribute to advancements in medicine.

• 40114-49-6(1-benzylpiperidin-3-one)
• 1260825-25-9(1-Benzyl-3-oxopiperidine-4-carbaldehyde)
• 146407-32-1(1-Benzyl-azepan-3-one)
• 50866-56-3(1-Benzylpiperidine-3,5-dione)
• 10315-08-9(1-Azoniabicyclo[2.2.2]octane,3-oxo-1-(phenylmethyl)-, bromide (1:1))
• 73385-13-4(3,5-Piperidinedione, 1-(phenylmethyl)-, hydrochloride)
• 1303968-15-1(1-Benzyl-4-methylpiperidin-3-one hydrochloride)
• 32018-96-5(1-Benzyl-4-methylpiperidin-3-one)
• 346694-73-3(1-benzylpiperidin-3-one;hydrate;hydrochloride)
• 66603-34-7(1-Benzyl-azepan-3-one hydrochloride)